Shenzhen Lifotronic Technology 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Ming Long Hu

최고 경영자

CN¥1.1m

총 보상

CEO 급여 비율	n/a
CEO 임기	4yrs
CEO 소유권	4.9%
경영진 평균 재임 기간	4yrs
이사회 평균 재임 기간	4yrs

최근 관리 업데이트

Recent updates

Is Shenzhen Lifotronic Technology (SHSE:688389) A Risky Investment?

Oct 24

Investors Still Aren't Entirely Convinced By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Earnings Despite 33% Price Jump

Oct 02

Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital

Aug 16

Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?

Jul 25

Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E

May 24

Shenzhen Lifotronic Technology (SHSE:688389) Might Have The Makings Of A Multi-Bagger

Apr 17

CEO

Ming Long Hu (55 yo)

4yrs

테뉴어

CN¥1,089,700

보상

Mr. Ming Long Hu is Director & GM of Shenzhen Lifotronic Technology Co., Ltd. from November 02, 2020. He was Director and Deputy General Manager of Shenzhen Lifotronic Technology Co., Ltd.He was Deputy Ge...

리더십 팀

이름	위치	테뉴어	보상	소유권
Ming Long Hu	Director & GM	4yrs	CN¥1.09m	4.91% CN¥ 326.5m
Hong Wang	CFO & Director	4yrs	CN¥630.60k	0.54% CN¥ 36.0m
Ying Zeng	Director & Deputy GM	4yrs	CN¥1.05m	4.59% CN¥ 305.5m
Liang Qiu	Deputy General Manager	4yrs	CN¥935.00k	0.95% CN¥ 63.5m
NA NA	Board Secretary	less than a year	데이터 없음	데이터 없음

4.0yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: 688389 의 관리팀은 경험 ( 4 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Ming Long Hu	Director & GM	4yrs	CN¥1.09m	4.91% CN¥ 326.5m
Hong Wang	CFO & Director	4yrs	CN¥630.60k	0.54% CN¥ 36.0m
Ying Zeng	Director & Deputy GM	4yrs	CN¥1.05m	4.59% CN¥ 305.5m
Xiancheng Liu	Chairman of the Board of Directors	4yrs	CN¥977.60k	29.39% CN¥ 2.0b
Guanghui Yang	Independent Director	less than a year	데이터 없음	데이터 없음
Lei Xiang	Director	4yrs	CN¥577.90k	0.0091% CN¥ 605.5k
Qiaowu Cai	Independent Director	4yrs	CN¥80.00k	데이터 없음
Min Liu	Chairman of the Supervisory Board	4yrs	데이터 없음	0.59% CN¥ 39.0m
Jun Yang	Supervisor	4yrs	데이터 없음	0.18% CN¥ 11.9m
Dawei Li	Deputy GM & Director	less than a year	CN¥759.20k	0.85% CN¥ 56.3m

4.0yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 이사회: 688389 의 이사회는 경험(평균 재직 기간 4 년)으로 간주됩니다.

Shenzhen Lifotronic Technology 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Shenzhen Lifotronic Technology Co., Ltd., Annual General Meeting, Apr 12, 2024

Less than half of directors are independent

Recent updates

Price target increased by 7.5% to CN¥22.45

Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.16 in 3Q 2023)

Is Shenzhen Lifotronic Technology (SHSE:688389) A Risky Investment?

Investor sentiment deteriorates as stock falls 20%

Investors Still Aren't Entirely Convinced By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Earnings Despite 33% Price Jump

New minor risk - Share price stability

Shenzhen Lifotronic Technology Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 19%

Price target decreased by 12% to CN¥20.87

Second quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.11 in 2Q 2023)

Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital

Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?

Shenzhen Lifotronic Technology Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024

Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E

Upcoming dividend of CN¥0.28 per share

First quarter 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.21 in 1Q 2023)

Shenzhen Lifotronic Technology (SHSE:688389) Might Have The Makings Of A Multi-Bagger

Shenzhen Lifotronic Technology Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Shenzhen Lifotronic Technology Co., Ltd., Annual General Meeting, Apr 12, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 16%

Now 21% undervalued

Investor sentiment improves as stock rises 18%

Third quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.12 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.079 in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.16 in 1Q 2022)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment improved over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.09 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.079 (vs CN¥0.07 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS misses analyst expectations

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.09 (vs CN¥0.06 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.07 (vs CN¥0.071 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.09 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.34 (vs CN¥0.26 in FY 2019)

New 90-day high: CN¥24.00

Investor sentiment deteriorated over the past week

New 90-day low: CN¥18.77

New 90-day low: CN¥18.85

New 90-day low: CN¥24.90

Third quarter earnings released

Shenzhen Lifotronic Technology Co., Ltd. to Report Q3, 2020 Results on Oct 17, 2020

New 90-day low - CN¥27.07

First half earnings released

Shenzhen Lifotronic Technology Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령